Family Medicine

Top Story

CMV load a potential endpoint in transplant infection trials

September 24, 2017

Although symptomatic cytomegalovirus disease is typically the endpoint in clinical trials involving organ recipients, viral load can act as a surrogate endpoint, according to researchers.

Several associations between viremia and actual disease in cytomegalovirus (CMV) suggest that there are advantages to using viral load as an endpoint, they wrote in Clinical Infectious Diseases.

Meeting News

Experimental oral diabetes drug appears safe, effective in Japanese adults

September 23, 2017
Imeglimin, part of a new class of oral agents for type 2 diabetes that target mitochondrial bioenergetics, was found to be safe and effective in Japanese adults…

Fall prevention: What you need to know

September 22, 2017
Today marks Falls Prevention Awareness Day. Organized by the National Council on Aging, observance of the day on the first day of fall has grown across the United States…
Meeting News

Novel oxycodone abuse-deterrent formula effective for chronic pain

September 22, 2017
Oxycodone DETERx ER, an extended-release, abuse-deterrent drug, safely and effectively managed chronic pain in patients with poorly managed pain previously treated with…
More Headlines »
CME

The Role of the Inflammatory Cascade in the Pathogenesis and Treatment of Psoriatic Arthritis: New and Emerging Therapies

This activity is supported by educational grants from Celgene Corporation and Novartis Pharmaceuticals Corporation.

The workings of the inflammatory cascade are not fully defined, but recent findings have demonstrated roles for novel…
More »
GI Bookshelf

Question 43: Caroli's Disease, What Do I Need to Know?

From Curbside Consultation of the Pancreas: 49 Clinical Questions
More »
Resource Centers
American Association of Nurse Practitioners National Conference

American Association of Nurse Practitioners National Conference

Video
Meeting News

VIDEO: Choosing the best technologies, mobile apps for your practice

September 19, 2017
More »
Advertisement
Advertisement